NS

Nunzio Sciammetta

Merck: 23 patents #390 of 9,382Top 5%
LY Lycera: 5 patents #14 of 35Top 40%
Pfizer: 2 patents #2,078 of 5,153Top 45%
Overall (All Time): #159,040 of 4,157,543Top 4%
25
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12319671 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof Hua Zhou, John J. Acton, III, Michael J. Ardolino, Yi-Heng Chen, Peter H. Fuller +15 more 2025-06-03
12157727 Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Yongxin Han, Yongqi Deng, Hua Zhou, Meredeth A. McGowan, Hongjun Zhang +3 more 2024-12-03
11498904 Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Yongxin Han, Abdelghani Achab, Indu T. Bharathan, Xavier Fradera, Derun Li +1 more 2022-11-15
11319295 Substituted phenyloxetane and phenyltetrahydrofuran compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Catherine White, Meredeth A. McGowan, Yongxin Han 2022-05-03
11319283 Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Meredeth A. McGowan, Abdelghani Achab, Xavier Fradera, Yongxin Han, Derun Li +6 more 2022-05-03
11208407 Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Hua Zhou, Abdelghani Achab, Xavier Fradera, Yongxin Han, Derun Li +3 more 2021-12-28
11111232 Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Catherine White, Abdelghani Achab, Indu T. Bharathan, Xavier Fradera, Yongxin Han +7 more 2021-09-07
11103493 Substituted pyridinyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Hua Zhou, Xavier Fradera, Yongxin Han, Meredeth A. McGowan, Catherine White +1 more 2021-08-31
10995085 Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Yongxin Han, Abdelghani Achab, Yongqi Deng, Xavier Fradera, Craig R. Gibeau +8 more 2021-05-04
10745364 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2020-08-18
10647705 Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Yongxin Han, Abdelghani Achab, Yongqi Deng, Xavier Fradera, Craig R. Gibeau +8 more 2020-05-12
10538497 Compounds as indoleamine 2,3-dioxygenase inhibitors Yongxin Han, Abdelghani Achab, Purakkattle Biju, Yongqi Deng, Xavier Fradera +9 more 2020-01-21
10508108 Tricyclic compounds as inhibitors of mutant IDH enzymes Christian Fischer, Stephane L. Bogen, Matthew L. Childers, Francesc Xavier Fradera Llinas, J. Michael Ellis +17 more 2019-12-17
10442819 Tricyclic compounds as inhibitors of mutant IDH enzymes Christian Fischer, Stephane L. Bogen, Matthew L. Childers, Francesc Xavier Fradera Llinas, J. Michael Ellis +28 more 2019-10-15
10221146 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2019-03-05
10221142 Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof Blair T. Lapointe, Peter H. Fuller, Hakan Gunaydin, Kun Liu, Benjamin Wesley Trotter +5 more 2019-03-05
10086000 Tricyclic compounds as inhibitors of mutant IDH enzymes Christian Fischer, Stephane L. Bogen, Matthew L. Childers, Francesc Xavier Fradera Llinas, Alexander Kim +9 more 2018-10-02
9809561 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2017-11-07
9783511 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +6 more 2017-10-10
9663522 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, John MacLean, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony +2 more 2017-05-30
9663502 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more 2017-05-30
9556168 N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Corey E. Bienstock, John MacLean, Hongjun Zhang, Richard Thomas Beresis +2 more 2017-01-31
9487490 3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, John MacLean, Hongjun Zhang, Richard Thomas Beresis, Dongshan Zhang +3 more 2016-11-08
8685977 Chemical compounds Andrew Simon Bell, Alan Daniel Brown, Russell Andrew Lewthwaite, Ian Roger Marsh, David S. Millan +6 more 2014-04-01
8592629 Sulfonamide derivatives as Nav 1.7 inhibitors Andrew Simon Bell, Alan Daniel Brown, Marcel John De Groot, Russell Andrew Lewthwaite, Ian Roger Marsh +6 more 2013-11-26